- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05258526
Home Based Exercise for Patients With Breast or Prostate Cancer (The BENEFIT-CA Study) (BENEFIT-CA)
Home Based Exercise for Patients With Breast or Prostate Cancer During Treatment: a Feasibility Trial (The BENEFIT-CA Study)
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
This feasibility trial aims to assess a home-based exercise program, including a 3-month intervention of structured physical activity and health education for individuals with breast or prostate cancer. The main objective of this trial is to assess the adherence of cancer patients to a program of structured exercise, mixed with a health education approach, implemented and accompanied in a remote approach.
The data collection will include variables related to: (a) recruitment and retentions rates; (b) attendance to exercise sessions; (c) fatigue and quality of life levels; (d) functional capacity levels; (e) adverse events related or not to the study; (f) patient selected outcomes.
Type d'étude
Inscription (Anticipé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Daniel Umpierre de Moraes, PhD
- Numéro de téléphone: 555133596332
- E-mail: danielumpierre@hcpa.edu.br
Sauvegarde des contacts de l'étude
- Nom: Larissa Xavier Neves da Silva, Master
- Numéro de téléphone: 555133596332
- E-mail: larissaxns@gmail.com
Lieux d'étude
-
-
Rio Grande Do Sul
-
Porto Alegre, Rio Grande Do Sul, Brésil, 90035-007
- Recrutement
- Hospital de Clinicas de Porto Alegre
-
Contact:
- Daniel Umpierre de Moraes, PhD
- Numéro de téléphone: 555133596332
- E-mail: danielumpierre@hcpa.edu.br
-
Contact:
- Larissa Xavier Neves da Silva, MSc
- Numéro de téléphone: 555133596332
- E-mail: larissaxns@gmail.com
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- eighteen years old minimum;
- be living in Porto Alegre or metropolitan region;
- breast cancer stage 0 - III OR
- localized prostate cancer;
- undergoing hormonal treatment / manipulation in isolation or combined with other therapies three months prior to the entrance in the study;
- hormonal therapy / manipulation planned to be active throughout the study duration;
- not engaged in any exercise training for more than once a week for the past 6 months;
- in case of previous surgical procedure, the patient must have medical clearance at the moment of the contact to begin the study or be cleared to do so in the near future (up to two weeks).
Exclusion Criteria:
- metastatic phase / progression of the disease or active regional location prior to beginning of the study;
- inability to understand the terms and conditions of study due to language, hearing, cognitive or severe psychiatric issues;
- another family member, who lives at the same residence, participating in the study;
- planning to move or major absence (more than two weeks) during the study;
- history of cardiovascular disease (except controlled hypertension) or severe cardiopulmonary disease, as well as history of heart attack, revascularization procedures, profound venous thrombosis, encephalic vascular accident (brain stroke) or pulmonary embolism in the past twelve months;
- chronic pulmonary disease that requires oxygen or corticosteroid therapy;
- kidney disease with or that is going to begin the use of dialysis or waiting for a kidney transplant;
- severe nausea, anorexia or any other condition which does not allow to perform physical exercise;
- medical contraindication to exercise training.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: Home-based exercise program
This is a single study arm consisting of a home-based exercise program for individuals with breast or prostate cancer during active treatment.
|
The intervention will be based on a remote approach, lasting 12 weeks.
The training routine will consist of aerobic (walking), muscle strengthening and stretching exercises, with a frequency of three days per week.
The contents related to the exercise prescription will be made available by phone call, text messages and short videos for exercise demonstration.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Trial adherence
Délai: Up to12 weeks.
|
Proportion of self-reported exercise episodes (out of 36 episodes, total) during the study.
|
Up to12 weeks.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Recruitment yields
Délai: Up to 8 weeks before allocation to the study intervention.
|
Proportion of included participants (who signed the informed consent) in relation to the total number of screened individuals for eligibility.
|
Up to 8 weeks before allocation to the study intervention.
|
Adverse events throughout the study
Délai: Up to 12 weeks.
|
Self-reported adverse events, related or not to the study.
These measures will be mostly received by phone calls or text messaging.
|
Up to 12 weeks.
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Fatigue levels at baseline and at the end of the study
Délai: Baseline; Week 12.
|
Fatigue scores using specific questionnaires of Functional Assessment of Cancer Therapy (FACT questionnaire) for breast or prostate cancer patients.
|
Baseline; Week 12.
|
Quality of life, based on the Functional Assessment of Cancer Therapy (FACT questionnaire)
Délai: Baseline; Week 12.
|
Quality of life scores using specific questionnaires of FACT (Functional Assessment of Cancer Therapy) for breast or prostate cancer patients.
|
Baseline; Week 12.
|
Walking capacity
Délai: Baseline; Week 12.
|
Total distance (in meters) performed during the six minute walk test.
|
Baseline; Week 12.
|
Handgrip strength
Délai: Baseline; Week 12.
|
Maximum strength (in kgf) achieved by both hands in a handgrip test using a hand dynamometer.
|
Baseline; Week 12.
|
Abdominal circumference
Délai: Baseline; Week 12.
|
Anthropometric measure of the highest abdominal circumference, using a metallic measuring tape.
|
Baseline; Week 12.
|
Physical activity levels
Délai: Single assessment at baseline.
|
Physical activity calculated in minutes and intensity per week, of physical activity using the International Physical Activity Questionnaire (IPAQ).
|
Single assessment at baseline.
|
Patient selected outcomes
Délai: Week 12.
|
Through the development of the study, participants will be asked to engage in a focal group to discuss outcomes relevant to be assessed in trials with exercise interventions targeted for patients with breast or prostate cancer.
|
Week 12.
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Daniel Umpierre de Moraes, PhD, Hospital de Clinicas de Porto Alegre
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2021-0262
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Files will be as de-identified as possible before public data sharing. After data protection and data handling routines, de-identified data will be readily available to all project contributors. We consider research data gathered from data collection from research participants pertains primarily to these individuals. Therefore, all individual data will be available to their owners throughout the project. Structured data that will result from this research project will pertain to the PI (Daniel Umpierre), who will be responsible for data integrity, and to the institution (Hospital de Clinicas de Porto Alegre).
The specific structure for data sharing as well as plataforms are still to be defined. As soon, we define the remaining details of our data sharing strategy the IPD plan will be updated.
Délai de partage IPD
Due to space and management constraints, we are planning:
- To retain and store project documentation (informed consents, IRB communication, subjects' communication) for at least 10 years after the study completion (anticipated time: up to 2033).
- To retain and share project resources (instruments, intervention materials) as long as public repositories (e.g., Zenodo, OSF, figshare) provide sharing services at no cost.
- To retain and share datasets as long as public repositories (e.g., Zenodo, OSF, figshare) provide sharing services at no cost.
Critères d'accès au partage IPD
Type d'informations de prise en charge du partage d'IPD
- Protocole d'étude
- Formulaire de consentement éclairé (ICF)
- Rapport d'étude clinique (CSR)
- Code analytique
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Cancer du sein
-
AstraZenecaRecrutementAdv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian CancerEspagne, États-Unis, Belgique, Royaume-Uni, France, Hongrie, Canada, Corée, République de, Australie
Essais cliniques sur Home based exercise training
-
Dartmouth-Hitchcock Medical CenterUnited States Department of DefenseRecrutementLésions cérébrales, traumatiques | Épilepsie, TraumatiqueÉtats-Unis
-
University of PlymouthPas encore de recrutementMaladie de Parkinson | ParkinsonRoyaume-Uni
-
Heidelberg UniversityEmory University; University Hospital Heidelberg; University of ArizonaComplétéLa dépression | Couples (personnes)Allemagne